A detailed history of Financial Avengers, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Financial Avengers, Inc. holds 326 shares of MRK stock, worth $32,443. This represents 0.02% of its overall portfolio holdings.

Number of Shares
326
Previous 324 0.62%
Holding current value
$32,443
Previous $40,000 7.5%
% of portfolio
0.02%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$111.15 - $128.97 $222 - $257
2 Added 0.62%
326 $37,000
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $123 - $132
1 Added 0.31%
324 $40,000
Q1 2024

May 10, 2024

BUY
$113.24 - $131.95 $339 - $395
3 Added 0.94%
323 $42,000
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $200 - $218
2 Added 0.63%
320 $34,000
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $205 - $228
2 Added 0.63%
318 $32,000
Q2 2023

Aug 04, 2023

BUY
$108.61 - $118.38 $217 - $236
2 Added 0.64%
316 $36,000
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $205 - $229
2 Added 0.64%
314 $33,000
Q4 2022

Feb 06, 2023

BUY
$87.44 - $112.11 $174 - $224
2 Added 0.65%
312 $34,000
Q3 2022

Nov 04, 2022

SELL
$84.53 - $94.96 $1,859 - $2,089
-22 Reduced 6.63%
310 $27,000
Q2 2022

Aug 16, 2022

BUY
$83.49 - $94.64 $166 - $189
2 Added 0.61%
332 $30,000
Q1 2022

May 11, 2022

BUY
$73.51 - $82.4 $147 - $164
2 Added 0.61%
330 $27,000
Q4 2021

Feb 08, 2022

BUY
$72.28 - $90.54 $12,721 - $15,935
176 Added 115.79%
328 $25,000
Q3 2021

Nov 01, 2021

SELL
$71.68 - $78.83 $13,905 - $15,293
-194 Reduced 56.07%
152 $11,000
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $210 - $233
3 Added 0.87%
346 $27,000
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $206 - $243
3 Added 0.88%
343 $26,000
Q4 2020

Feb 05, 2021

BUY
$71.77 - $79.65 $24,401 - $27,081
340 New
340 $28,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Financial Avengers, Inc. Portfolio

Follow Financial Avengers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Avengers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Avengers, Inc. with notifications on news.